CC Capital Still Working on Bid for Australia’s Insignia
Insignia Financial Update: Australian wealth manager Insignia Financial announced that CC Capital Partners is still preparing a binding offer, nearly four months after gaining access to the company's financials.
Bain Capital Withdrawal: While CC Capital continues its efforts, rival bidder Bain Capital withdrew from the process two months after initially being granted access in March.
Trade with 70% Backtested Accuracy
Analyst Views on BN
About BN
About the author

- Hedge Fund IPO Plans: Bill Ackman has filed to make Pershing Square's hedge fund and a new closed-end fund publicly traded in a dual IPO, allowing investors to gain a small stake in the hedge fund management company, which is expected to attract significant investor interest.
- Brookfield Corp. Investment Highlights: Ackman's portfolio allocates 17.5% to Brookfield Corp., which anticipates a 25% increase in distributable earnings this year and aims to grow its invested assets from $120 billion to $600 billion, indicating strong growth potential.
- Uber Business Growth: Uber, comprising 15.9% of Ackman's investments, has shown resilience despite self-driving car threats, with its core business benefiting from user growth and increased trip frequency, leading to an EBITDA margin rise to 4.6%, with expectations for continued improvement.
- Alphabet AI Developments: Ackman holds 14.8% in Alphabet, which has enhanced search engine engagement through AI technology, accelerating ad revenue growth in 2025, while demand for cloud computing services is surging, expected to drive future revenue growth.
- IPO Launch: Bill Ackman has filed to publicly trade shares of his hedge fund and a new closed-end fund through a dual IPO, which is expected to attract investor interest in his concentrated investment portfolio.
- Brookfield Growth Potential: Ackman is optimistic about Brookfield Corp., anticipating a 25% increase in distributable earnings in 2025, aligning with management's annualized target from the investor day, indicating strong long-term growth prospects.
- Uber's Market Position: Despite potential threats from self-driving cars, Ackman believes Uber's valuation remains attractive, with its core business showing a 35% year-over-year EBITDA growth driven by user growth and increased trip frequency.
- Surge in Google Cloud Demand: Google Cloud has seen a surge in demand amid the AI boom, with revenue growing 48% year-over-year in the final quarter of 2025, and management guiding for $175 billion to $185 billion in capex for 2026 to meet rising compute needs.
Bill Ackman's New Strategy: After a failed U.S. fund offering in 2024, billionaire investor Bill Ackman is incorporating stock in his management company, Pershing Square Inc., to attract investors.
Improved Terms: The terms of the new offering are more favorable compared to what Ackman proposed two years ago, potentially making it more appealing to investors.
Caution Advised: Despite the improved terms, investors are encouraged to carefully consider their participation in the offering.
Mary Poppins Reference: Ackman's approach to sweetening the deal is likened to the advice from Mary Poppins, suggesting a creative strategy to make the investment more attractive.
- Fundraising Initiative: Pershing Square Capital Management has filed to list on the NYSE, aiming to raise between $5 billion and $10 billion through the new closed-end fund Pershing Square USA at a share price of $50, having already secured $2.8 billion in commitments.
- Market Volatility Strategy: In a letter to investors, Ackman emphasized that market chaos is a feature of his investment strategy, allowing him to acquire high-quality companies at discounted prices without affecting their long-term intrinsic value.
- Historical Performance: Pershing Square achieved a return of approximately 34% in 2025, nearly doubling the S&P 500's 18%, demonstrating its ability to capitalize on opportunities during market disruptions.
- Market Challenges: Despite the ambitious fundraising plan, the market is currently skeptical of the closed-end fund structure, with shares falling 11% on the first day to around $22.64, leading Ackman to acknowledge that investors need a “significant leap of faith” to support this structure.
- Brookfield Renewable: Brookfield Renewable is expected to double its revenue from $5.1 billion to $10.7 billion by 2028, driven primarily by the rapid growth of cloud computing and AI markets, while long-term renewable power agreements with Microsoft and Google will further solidify its market position.
- Stable Dividend Yield: Brookfield Renewable offers a forward yield of 5.2%, and although it has not yet achieved consistent profitability, its adjusted EBITDA is projected to grow at an 8% CAGR from 2025 to 2028, indicating strong future earnings potential.
- Enterprise Products Partners: Enterprise Products Partners operates over 50,000 miles of pipeline across 27 states, with an expected operational distributable cash flow of $7.9 billion in 2025, easily covering its $4.8 billion in distributions, ensuring a sustainable 5.9% yield.
- Market Competitive Advantage: While Enterprise Products Partners is less aggressive in expanding its pipeline network compared to competitors, its lower debt levels and stable revenue model provide relative safety and attractiveness in turbulent market conditions.
- Brookfield Corporation Undervalued: Brookfield Corporation, with a market cap of $105 billion, has seen its stock drop 2.99% amid market volatility; however, it is projected to achieve over 20% earnings growth in the next five years, potentially closing the valuation gap of its holdings and driving stock appreciation.
- SSR Mining Benefits from Rising Gold Prices: As geopolitical tensions escalate, gold prices have surged again, leading SSR Mining's stock to hit new highs; with adjusted earnings expected to grow significantly due to high gold prices, the stock currently trades at less than 9 times forward earnings, indicating strong investment potential.
- Teva Pharmaceuticals' Ongoing Transformation: Israel-based Teva Pharmaceuticals is transitioning from a generic drugmaker to a branded pharmaceutical company, with its branded drug business growing at a mid-double-digit rate; as its drug pipeline advances, steady sales and profitability growth are expected, with a current forward P/E of 12.5 that could rise to the mid-teens.
- Market Trends and Investment Opportunities: Despite multiple challenges in the market, certain stocks are benefiting from trends like rising gold prices and the adoption of generative AI; even with just $1,000, investors can consider these stocks, which may yield substantial long-term returns.












